Your browser doesn't support javascript.
loading
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab.
Arnold, Jack; Dass, Shouvik; Twigg, Sarah; Jones, Colin H; Rhodes, Ben; Hewins, Peter; Chakravorty, Mithun; Courtney, Phil; Ehrenstein, Michael; Md Yusof, Md Yuzaiful; Vital, Edward M.
Afiliación
  • Arnold J; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
  • Dass S; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds.
  • Twigg S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
  • Jones CH; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds.
  • Rhodes B; Bradford Teaching Hospitals NHS Foundation Trust, Bradford.
  • Hewins P; York Teaching Hospitals NHS Foundation Trust, York.
  • Chakravorty M; University Hospitals Birmingham NHS Foundation Trust, Birmingham.
  • Courtney P; University Hospitals Birmingham NHS Foundation Trust, Birmingham.
  • Ehrenstein M; Nottingham University Hospitals NHS Trust, Nottingham.
  • Md Yusof MY; Nottingham University Hospitals NHS Trust, Nottingham.
  • Vital EM; University College London, London, UK.
Rheumatology (Oxford) ; 61(12): 4905-4909, 2022 11 28.
Article en En | MEDLINE | ID: mdl-35266512
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article